Intravenous Catheters Market Size

Market Outlook:

Intravenous Catheters Market was over USD 8.5 Billion in 2023 and is set to surpass USD 18 Billion by end of the year 2032, growing at over 7.5% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 8.5 Billion
• CAGR (2024-2032): 7.5%
• Forecast Year Value (2032): USD 18 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

One major growth driver for the Intravenous Catheters market is the increasing prevalence of chronic diseases that require continuous monitoring and treatment. Conditions such as diabetes, cardiovascular diseases, and cancer require patients to have access to intravenous therapy, thereby boosting the demand for intravenous catheters. Additionally, the rising geriatric population worldwide is another factor driving market growth, as elderly individuals are more susceptible to various health issues that may necessitate the use of intravenous catheters for treatment. Furthermore, technological advancements in catheter design and materials have improved patient comfort and safety, further fueling market growth.

Another growth driver for the Intravenous Catheters market is the growing focus on infection prevention and control. Healthcare-associated infections are a significant concern in hospitals and other healthcare settings, leading to increased emphasis on the use of sterile and antimicrobial catheters to reduce the risk of infection transmission. With healthcare providers increasingly prioritizing patient safety and quality of care, the demand for advanced intravenous catheters that help prevent infections is expected to grow substantially in the coming years.

Industry

Report Scope

Report Coverage	Details
Segments Covered	Product Type, Gauge Size, Lumen, Material, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	AngioDynamics, Argon Medical Devices, Becton, Dickinson and Company, B. Braun Melsungen AG, Boston Scientific, ICU Medical, Medilivescare Manufacturing Pvt.., Medtronic plc, Nipro, Poly Medicure., Teleflex Incorporated, Terumo, Vygon

One major restraint facing the Intravenous Catheters market is the risk of complications associated with catheter insertion and use. Complications such as infection, thrombosis, and phlebitis can occur during or after catheter placement, leading to adverse patient outcomes and increased healthcare costs.